Tianjin Lisheng Pharmaceutical Co., Ltd. (stock code 002393), founded in 1951, is a pharmaceutical enterprise growing up with the pace of industrial revitalization in New China. For decades, the company has been widely praised by the society for producing high-quality drugs to serve human health, and has made positive contributions to China's medical and health undertakings.
The company now has two wholly-owned subsidiaries: Tianjin Central Pharmaceutical Co., Ltd. (hereinafter referred to as "Central Pharmaceutical") and Tianjin Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as "biochemical pharmaceutical"). It has four joint-stock companies: Tianjin Pharmaceutical Group Finance Co., Ltd., Tianjin Tianbian Pharmaceutical Co., Ltd., Tianjin ledun traditional Chinese Medicine Co., Ltd. and Tianjin Pharmaceutical Group Marketing Management Co., Ltd. Central Pharmaceutical Co., Ltd., a wholly-owned subsidiary, holds shares in Tianshili Holding Group Co., Ltd.
The company is recognized as a national high-tech enterprise and a national green factory. The products cover 15 categories, with a total of 243 drug approval numbers, involving Chinese and Western tablets, capsules, oral liquids, granules, biological agents and APIs. It has many "Chinese famous trademarks" and "Tianjin famous trademarks". The marketing network covers the whole country, and some products are sold all over the world. Among them, core products such as "shoubishan" brand indapamide tablets, "shifuni" brand cefdini dispersible tablets, Maren soft capsules, nadroparin calcium injection have obtained high market recognition.
Lisheng people always adhere to the business philosophy of "being a good person and doing a good job in medicine", focusing on the important treatment fields such as cardio cerebrovascular, anesthesia, analgesia and spirit, anti infection, anti diabetes, tonic and so on, and constantly improving the quality of human life.
In the future, the company will firmly focus on the development path of high-quality innovation and upgrading of its main business, maintain strategic determination, strengthen development confidence, stick to the goal, forge ahead, and make progress towards the development goal of an advanced pharmaceutical enterprise with core competitiveness, industry influence and international ability, so as to make Lisheng become an excellent pharmaceutical enterprise worthy of the trust of patients.